Adam Lytle

Adam Lytle is a Director at Polaris, a leading Nordic mid-market private equity house headquartered in Copenhagen. He joined Polaris in 2018 to help build and run the firm's investment activity across Sweden and Denmark, targeting mid-market companies in the roughly EUR 50–300m enterprise-value range across industrials, services, consumer, and healthcare.

Before Polaris, Adam spent roughly twelve years in London focused on Nordic and European mid-market private equity. Most recently he was a Senior Vice President at AEA Investors (2010–2018). Earlier he was an Investment Manager at Argan Capital (2008–2010) and an Associate on J.P. Morgan's European Industrials team (2006–2008), having started his career at Enskilda Securities Corporate Finance in 2005. Between 2005 and 2009 he also held positions at the medical-technology companies Gambro (Stockholm) and Coloplast (Humlebæk, Denmark), giving him early operating/sector exposure to healthcare and medtech.

Adam holds an M.Sc. in Business Administration with a major in Finance from the Stockholm School of Economics. His combination of Nordic roots, London mid-market PE experience, and healthcare/industrial sector background underpins his role sourcing and executing Polaris deals in Sweden and Denmark.

• Invests through Polaris Private Equity, taking majority equity stakes in established, profitable Nordic mid-market companies — this is control-buyout investing, not angel/seed.
• Target size: enterprise values of roughly EUR 50–300m (Polaris literature cites EUR 50–250m/300m across funds).
• Core sectors: industrials/manufacturing, business and commercial services, consumer, and healthcare.
• Geography: primarily Sweden and Denmark; Polaris expanded into Sweden from 2005 and Adam is part of that Swedish-focused effort.
• Approach: "Power of Partnership" — Polaris positions itself as an active, hands-on owner partnering with management teams to build value over a multi-year hold, rather than a passive or minority investor.